Folgen
Alyssa Siefert
Alyssa Siefert
Bestätigte E-Mail-Adresse bei yale.edu
Titel
Zitiert von
Zitiert von
Jahr
Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines
SL Demento, AL Siefert, A Bandyopadhyay, FA Sharp, TM Fahmy
Trends in biotechnology 29 (6), 294-306, 2011
2022011
Investigation of peanut oral immunotherapy with CpG/peanut nanoparticles in a murine model of peanut allergy
KD Srivastava, A Siefert, TM Fahmy, MJ Caplan, XM Li, HA Sampson
Journal of Allergy and Clinical Immunology 138 (2), 536-543. e4, 2016
1022016
Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy
AL Siefert, MJ Caplan, TM Fahmy
Biomaterials 97, 85-96, 2016
752016
Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA
S Zeller, CS Choi, PD Uchil, HS Ban, A Siefert, TM Fahmy, W Mothes, ...
Chemistry & biology 22 (1), 50-62, 2015
452015
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin
JS Lee, P Han, R Chaudhury, S Khan, S Bickerton, MD McHugh, HB Park, ...
Nature Biomedical Engineering 5 (9), 983-997, 2021
362021
Cell-specific siRNA delivery by peptides and antibodies
SK Lee, A Siefert, J Beloor, TM Fahmy, P Kumar
Methods in Enzymology 502, 91-122, 2012
312012
Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model
AL Siefert, A Ehrlich, MJ Corral, K Goldsmith-Pestana, D McMahon-Pratt, ...
Biomaterials 108, 168-176, 2016
192016
The Yale Center for Biomedical Innovation and Technology (CBIT): one model to accelerate impact from academic health care innovation
AL Siefert, MS Cartiera, AN Khalid, MC Nantel, CR Loose, PG Schulam, ...
Academic Medicine 94 (4), 528-534, 2019
182019
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski
US Patent 9,610,250, 2017
162017
Skills beyond the Reading room: training in innovation and collaboration at a radiology hackathon
K Cooper, A Siefert, J Weinreb
Journal of the American College of Radiology 15 (3), 466-468, 2018
122018
Artificial antigen-presenting cells for immunotherapies
AL Siefert, TM Fahmy, D Kim
Cancer Nanotechnology: Methods and Protocols, 343-353, 2017
102017
Investigation of peanut oral immunotherapy using CpG/peanut-nanoparticles in a murine model of peanut allergy
KD Srivastava, A Siefert, T Fahmy, MJ Caplan, XM Li, HA Sampson
Journal of Allergy and Clinical Immunology 135 (2), AB235, 2015
52015
An integrated undergraduate biomedical engineering laboratory course
C Zapanta, W Ruder, J Newberg, P Glass, D Minhas, EG Osuna, LT Sun, ...
2009 Annual Conference & Exposition, 14.200. 1-14.200. 32, 2009
52009
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski
US Patent 10,603,276, 2020
42020
Yale CBIT: Catalyzing biomedical innovation
M Cartiera, A Siefert
12016
Biomimetic Nanosystems Targeting Antigen-Presenting Cells for Improved Immunotherapeutics
AL Siefert
Yale University, 2015
12015
Yale Center for Biomedical and Interventional Technology (CBIT)
A Siefert, J Zinter, P Schulam, C Loose, A Khalid, M Dempsey, J Zheng, ...
IJAMM, 2023
2023
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski
US Patent App. 17/399,544, 2022
2022
Nanolipogel vehicles for controlled delivery of different pharmaceutical agents
TM Fahmy, E Stern, RA Flavell, J Park, A Siefert, SH Wrzesinski
US Patent 11,173,119, 2021
2021
Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin (vol 5, pg 983, 2021)
JS Lee, P Han, R Chaudhury, S Khan, S Bickerton, MD McHugh, HB Park, ...
NATURE BIOMEDICAL ENGINEERING 5 (11), 1403-1403, 2021
2021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20